Pre-Existing Anti–Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy

Human gene therapy methods - United States
doi 10.1089/hgtb.2012.243
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Developing Immunologically Inert Adeno-Associated Virus (AAV) Vectors for Gene Therapy: Possibilities and Limitations

Current Pharmaceutical Biotechnology
BiotechnologyPharmaceutical Science
2014English

Adeno-Associated Virus (AAV) Vector and AAV Empty Particles

Nihon Ika Daigaku Igakkai Zasshi
2017English

Epitope Mapping of Human Anti-Adeno-Associated Virus Type 2 Neutralizing Antibodies: Implications for Gene Therapy and Virus Structure

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2000English

Transmission Electron Tomography of Adeno-Associated Virus (AAV)

Microscopy and Microanalysis
Instrumentation
2010English

Cancer Gene Therapy Using Adeno-Associated Virus Vectors

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2008English

Adeno-Associated Virus-Based Gene Therapy for CNS Diseases

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2016English

Adeno-Associated Virus Vectors for Gene Therapy, Volume 31.

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2006English

Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2007English

Bat Adeno-Associated Viruses as Gene Therapy Vectors With the Potential to Evade Human Neutralizing Antibodies

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy